Navigation Links
Treatment of First Patient in Phase I Clinical Trial of Bionomics' Anti-Cancer Drug BNC105
Date:2/25/2008

MELBOURNE, Australia, Feb. 26 /PRNewswire/ -- Bionomics Limited (ASX: BNO) today announced the initiation of treatment for the first patient in the Phase I trial of its anti-cancer drug, BNC105.

The BNC105 Phase I clinical trial involves treatment of patients with advanced cancer. Patients will be treated with BNC105 on days 1 and 8 of a 21 day cycle, over two cycles. The trial will be conducted at clinical sites within the Cancer Trials Australia network at the Royal Melbourne Hospital, the Peter MaCallum Cancer Centre and the Western Hospital in Melbourne.

Dr. Deborah Rathjen, CEO and Managing Director of Bionomics hailed the commencement of the Phase I trial as a significant milestone for the Company.

"We are excited to commence our trial of BNC105 and to announce our first patient has begun treatment," Dr Rathjen commented. "We will provide regular updates as we move through the trial, and I look forward to updating shareholders on our progress."

The primary objective for this trial is the evaluation of the safety and tolerability of BNC105. The results obtained from this trial will enable the identification of an appropriate dose of BNC105 for subsequent trials. Further objectives include, the evaluation of BNC105 pharmacokinetics and its activity against tumour vasculature and tumour growth.

BNC105 is a new type of anti-cancer drug called a Vascular Disruption Agent (VDA) which blocks the blood supply to a solid tumour, effectively "starving" the tumour of nutrients. Pre-clinical data indicates that BNC105 has a dual mechanism of action with the ability to not only block the supply of nutrients to the tumour but also to directly destroy cancer cells. In addition, BNC105 is retained in the tumour at high levels for an extended period of time, enhancing its' anti-cancer effect.

Although VDAs have strong potential for use in combination with traditional cancer treatment options, including chemotherapy, preclinical
'/>"/>

SOURCE Bionomics Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
3. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015  Merck KGaA, Darmstadt, Germany ... top-quality high-tech products in healthcare, life science and ... with the fertility technologies expert Genea Biomedx, an ... helping couples create families. With this partnership, Merck ... global market leader in drugs for Assisted Reproductive ...
(Date:5/28/2015)... , May 28, 2015 ... Testing Market - Size, Industry Analysis, Trends, Opportunities, Growth and ... reach $3.6 billion by 2020. The secondary syphilis testing ... 2020. Latin America , ... (LAMEA) market accounted for about 43% revenue share ...
(Date:5/28/2015)... , May 28, 2015  The recent flurry ... plans and employer groups scrambling to identify a ... major managed care plan, retail pharmacy chain, or ... $13.3 billion purchase of Catamaran, Rite Aid,s $2 ... to purchase Omni-Care for $10 billion are just ...
Breaking Medicine Technology:Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 2Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 4Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 3Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 2Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 3
... NEW YORK , April 27 Crash Cart ... films on the American healthcare system and medical malpractice, announces the launch ... 5 , 2010.  Copies of the film, directed by Ryan Flesher ... available for order beginning May 5 at www.CrashCartProductions.com .  ...
... Renal Therapies Division of B. Braun Medical Inc. (B. Braun) has ... dialysis effectiveness during treatment. , , ... http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO ) , , , ... B. Braun and already in use in Europe , is designed for ...
Cached Medicine Technology:'The Vanishing Oath,' the First Physician-Focused Documentary on the Dangers of the American Healthcare System, Launches on DVD May 5 2'The Vanishing Oath,' the First Physician-Focused Documentary on the Dangers of the American Healthcare System, Launches on DVD May 5 3B. Braun Renal Therapies Division Announces Availability of Adimea 2B. Braun Renal Therapies Division Announces Availability of Adimea 3
(Date:5/28/2015)... The Khanna Vision Institute announced the launch ... to make learning about treatment of keratoconus fun. Treatment ... This proliferation of treatment techniques has not reached the ... nuances of the cutting edge technologies. Dr.Khanna, medical director ... be boring and printed material can be onerous for ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Optimity ... and implementing innovative models of care for healthcare ... support alternative reimbursements and help operationalize contracting and ... also unveils a bi-weekly series of seven “ ... Outcomes Based Contracting. Optimity is a strategy, operations ...
(Date:5/28/2015)... The drug epidemic has struck the New College of ... 12th, 2015, by Bradenton , the campus sustained two ... victim, Dylan Besser (21) was a University of Central Florida ... overdose victim, Julian Toomsen-Hall (18) was also pronounced dead in ... on campus, the college has created a drug task force ...
(Date:5/28/2015)... 28, 2015 The report “Dystonia ... on the therapeutic development for Dystonia. Dystonia is ... abnormal, often repetitive, movements, postures, or both. Dystonia ... and backgrounds. The report strengthens R&D pipelines by ... and best-in-class products. Complete report on H1 2015 ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Dallas ... updated version of his patient education website ... redesign allows patients to readily access current educational ... dysfunction treatment, male urinary incontinence, prostate cancer treatment, ... of this website is to educate patients on ...
Breaking Medicine News(10 mins):Health News:Dr.Khanna Announced the Release of an Interactive Web Application for Keratoconus Treatment 2Health News:Optimity Advisors Now Offers Outcomes Based Contracting Services to Support Engagement Model For New Healthcare Innovative Models of Care 2Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 2Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 3Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Mark Allen MD, Dallas Urologist, Launches Updated Patient Education Website With a Focus on Prostate Cancer and Erectile Dysfunction Treatment 2
... be as prone to problem, study finds , , MONDAY, Jan. 21 ... of heart disease, especially among women, a new study finds. , ... at lower blood sugar levels than men, according to the report ... American College of Cardiology . , "The new definition of ...
... food is no friend of the waistline, new study finds , , ... you eat out, it,s where you choose to dine ... in neighborhoods with more fast-food restaurants are more likely to be ... study found. , "A lot of people have tried to ...
... of Flourish Studios, Dr. Julia,Rahn, has retained Empower Public ... and love. Flourish Studios is a multi-faceted learning,gallery that ... This 14,000 square foot facility blends the best of ... array of,artwork by Heather Gentile Collins, and the retail ...
... Expertise During a Key ... Growth Period for the Association, PLEASANT HILL, Calif., Jan. 21 ... Trainer, chief executive,officer and founder, Trainer Communications, to its Corporate Executive,Board ... the Y, which,is in the middle of a major capital fundraising ...
... (SHC),owned by RJR Insurance Services, Inc., one of the largest,captive-distribution ... distribution managers for 2008., Officers of Senior Healthcare ... President and Chief Executive Officer, RJR ... -- Chief Financial Officer -- Robert A. Douglas ...
... Md., Jan. 21 CBaySystems announced today,that it ... in the Greater,Baltimore Area by Baltimore SmartCEO magazine. ... companies in the Greater Baltimore area,based on employee ... employ 5,500 people and for the first time ...
Cached Medicine News:Health News:High Blood Sugar Boosts Women's Heart Disease Risk 2Health News:Eating Out Doesn't Guarantee Weight Gain 2Health News:Eating Out Doesn't Guarantee Weight Gain 3Health News:Flourish Studios Launches Campaign With Empower Public Relations 2Health News:Mount Diablo Region YMCA Names Local Business Leader, Susan Trainer, to Its Corporate Executive Board 2Health News:Mount Diablo Region YMCA Names Local Business Leader, Susan Trainer, to Its Corporate Executive Board 3Health News:Mount Diablo Region YMCA Names Local Business Leader, Susan Trainer, to Its Corporate Executive Board 4Health News:Senior Healthcare Consultants and Subsidiary Companies Announce Election of Officers & Distribution Managers 2Health News:Senior Healthcare Consultants and Subsidiary Companies Announce Election of Officers & Distribution Managers 3Health News:CBaySystems Again Named to the Baltimore List of Fastest Growing Companies 2
Tested by surgeons for functionality and ergonomy. Uses the Medifix C1301-1CCD camera head....
Large image and wide angle design for transurethral examination and treatment of the ureter and renal pelvis....
High intensity halogen lamp with built-in, switchable spare. Optical light concentrator to optimize existing light energy....
... Boston Keratoprosthesis consists of two plastic parts ... is then sutured into the patient's cornea ... has been under development since the 1960s ... FDA clearance in 1992. About 600 implantations ...
Medicine Products: